Botanix Pharmaceuticals Ltd has released a press release.
Successful renegotiation of API supply agreement
Earlier from Botanix Pharmaceuticals
- S&P DJI Announces March 2026 Quarterly Rebalance
- Appendix 4D and Half Year Report
- Botanix Receives Capital Raise Commitments of A$45 Million
- Trading Halt

